Search Medical Condition
Please enter condition
Please choose location from dropdown

Ningbo, China Clinical Trials

A listing of Ningbo, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (33) clinical trials

REALM China Extension Study

The purpose of this study is to conduct an investigator initiated observational study to continue to follow up the China subset of study participants for another 5 years after they complete participation in the REALM Study

Phase N/A

0.0 miles

Learn More »

Phase

0.0 miles

Learn More »

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

This is a single-arm, open-label, one center, dose escalation clinical study, to determine the safety and efficacy of infusion of autologous T cells engineered to express immune checkpoint antibody and chimeric antigen receptor targeting mesothelin in adult patients with mesothelin positive, recurrent or refractory malignant tumors.

Phase

0.0 miles

Learn More »

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

A total of 20 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

A total of 40 patients may be enrolled over a period of 1-2 years.

Phase

0.0 miles

Learn More »

Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

To evaluate the safety and efficacy of PEG Somatropin Injection (Jintrolong) in the treatment of short stature due to endogenous growth hormone deficiency (GHD) in the broad of population of children.

Phase

0.0 miles

Learn More »

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

The study is to verify atorvastatin effectiveness and safety in Chinese population, and explore the optimal atorvastatin regimens in high-to-moderate risk for ASCVD

Phase N/A

0.0 miles

Learn More »

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

IgA glomerulonephritis is the most common primary glomerulonephritis, and immunosuppression with steroids has been suggested to be a potential protective therapy, although the benefits and risks have not been clearly established. The TESTING study was established to compare the effects of oral methylprednisolone 0.8 mg/kg/day weaning over 6-8 months, to ...

Phase N/A

0.0 miles

Learn More »